# Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

> **NCT01666210** · PHASE2 · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Ocular Inflammation and Pain

## Interventions

- **DRUG:** OTX-DP (Dexamethasone punctum plug)
- **DRUG:** Placebo Vehicle Punctum Plug

## Key facts

- **NCT ID:** NCT01666210
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666210, "Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01666210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*